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Article abstract-Little information exists on the performance of black versus white patients with Alzheimer’s dis- 
ease on neuropsychological tests for dementia. In this study, we compared performance on the CERAD (Consortium to 
Establish a Registry for Alzheimer’s Disease) neuropsychological battery between white (n = 830) and black (n = 158) 
patients with Alzheimer’s disease enrolled in the CERAD study at 23 university medical centers in the United States. 
The black patients were older, had fewer years of formal education, and were more impaired in their activities of daily 
living than were the white patients. After controlling for these characteristics and for duration of the disease and 
severity of dementia, there were differences in the performance of black and white patients on several of the cognitive 
measures. Black patients scored lower than whites on tests of visual naming and constructional praxis and on the 
Mini-Mental State Examination. There were no statistical differences in performance on tests of fluency and word list 
memory. These findings suggest that cultural or experiential differences may modify performance on specific neuropsy- 
chological tests. These factors, in addition to age and educational background, should be considered when interpreting 
performance on neuropsychological tests in elderly black patients with dementia. 
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Studies of aging and Alzheimer’s disease (AD) have 
shown that differences in educational and cultural 
experiences can affect performance on cognitive 
Tests of intelligence, particularly tests 
based on general knowledge3 or naming@ and some 
tests of verbal learning and memory, are affected 
by these factors.’ Even nonverbal tests (eg, the 
Block Design subtest of the Wechsler Adult Intelli- 
gence Scale-Revised or tests of constructional 
praxis), often considered to be “culturally fair,” are 
affected by cultural background, resulting in mi- 
nority groups scoring less well on these measures 
than white comparison  group^.^,^-^^ 
* Although the term “African-American” has been used recently to refer 
to black Americans in order to emphasize cultural roots and deempha- 
size race, the term “black” has been used by researchers and notable 
black scholars in the literature on minority aging. To avoid confusion 
and for purposes of consistency, we use the term “black throughout the 
text to refer to the African-American group. 
A major challenge in cross-cultural studies of de- 
mentia is distinguishing differences in groups 
based on (1) cultural or experiential differences, (2) 
the effects of age, education, and other modifying 
variables, and (3) biological differences in the ill- 
ness per se. These alternatives are often difficult to 
evaluate because of a lack of information on the 
neuropsychological features of various dementias 
in different cultural, racial, and ethnic groups. This 
situation is changing, however, as the result of an  
increased interest in cross-cultural neuropsycholog- 
ical studies.13-16 
In the present investigation, we examined the 
performance of black and white patients with AD 
on tests frequently used to evaluate cognitive im- 
pairment caused by this disorder. By controlling for 
factors such as age, education, and duration and 
severity of dementia, this study specifically ad- 
dresses the role of racial factors (eg, cultural or ex- 
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periential differences) on neuropsychological test 
performance in dementia. The results underscore 
the importance of having norms based on cultural 
background when interpreting neuropsychological 
test performance in elderly black or other minority 
subjects with dementia. 
Methods. Subjects. The AD patient groups in this study 
consisted of 158 elderly blacks and 830 elderly whites re- 
cruited from 23 university medical centers participating 
in the Consortium to Establish a Registry for Alzheimer‘s 
Disease (CERAD). Each patient satisfied strict entry cri- 
teria that excluded serious neurologic, medical, and psy- 
chiatric disorders that could affect mentation. All sub- 
jects were English-speaking and were 50 years of age or 
older at entry into the study. Informed consent was ob- 
tained from each subject or from an appropriate care- 
giver by methods approved by the institutional review 
board at each center. 
Clinical assessment. Each patient enrolled in this 
project was examined by a physician with expertise in 
dementia. The clinical assessment, described else- 
where,17 consisted of a semistructured interview to deter- 
mine cognitive and functional status, a drug inventory, 
taking of depression and medical history, the six-item 
Short Blessed Test,18 and a general physical and neuro- 
logic examination. Diagnoses of either probable or possi- 
ble AD were made based on a modification of the criteria 
of the NINCDS-ADRDA Work Group.l9 The stage of 
severity of the dementia was quantified using the Clini- 
cal Dementia Rating scalez0 (CDR) and the activities of 
daily living measures from the Blessed Dementia Rating 
Scale.z1 Estimated duration of disease (in years) and 
scores from the Blessed Dementia Rating Scale and from 
the CDR were included in the analyses to control for 
severity and duration of illness. 
Neuropsychological tests. The CERAD neuropsycho- 
logical assessment battery was administered at each of 
the participating sites by trained, certified psychometri- 
cians whose ratings were independent of the physicians’ 
clinical evaluations. This battery of tests was designed to 
assess the basic cognitive functions affected in AD and 
includes the following measures, presented in their order 
of administration: 
1. Verbal fluency test Ifluencv), This test measures 
verbal production, semantic memory, and language.z2 It 
requires the subject to  name as many examples of ani- 
mals as possible within 1 minute. 
2. Boston- ‘ e: Testacidified (na ming), This test 
is a measure of visual naming and presents 15 line draw- 
ings of common objects from the Boston Naming Test.zs 
These items are stratified into three groups of five items 
each, representing objects of high (easy to name), medi- 
um, and low (hard to name) frequency of occurrence in 
the English language. The maximum possible score is 15. 
3. Mini-Mental State Exam ina t im (MMS E), The 
CERAD version is a slight modification of this well- 
known screen of cognitive function.z4 It measures orien- 
tation, language, concentration, constructional praxis, 
and memory. The serial subtraction subtest is replaced 
by the alternative test procedure, ie, spelling “world” 
backwards. The maximum possible score on the test re- 
mains 30. 
4. Wor d list memorv (word list learning). This is a 
free-recall memory tes t  t ha t  is included i n  the  
Alzheimer’s Disease Assessment Scale (ADAS)z6 and as- 
sesses learning ability for new verbal information. Three 
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trials of a 10-item word list are presented. On each trial, 
the 10 words are presented in a different order. The sub- 
ject is instructed to read each word aloud as  it is pre- 
sented. Immediately after each trial, the subject is asked 
to recall as many words as possible. The maximum possi- 
ble score on each trial is 10. To reduce the number of 
variables analyzed, performance on each of the three tri- 
als was summed to provide a total learning score. 
5. C o n s t r u c t i v  This task is also de- 
rived from the ADAS.zs It measures visuospatial and 
constructional abilities and requires the subject to copy 
four line drawings, presented in order of increasing com- 
plexity (circle, diamond, overlapping rectangles, cube). 
The total possible score is 11. 
6. Word 1-1 (delaved rec& This test assesses 
the subject’s ability to recall, after a 5-minute delay, the 
10 words given in the above-mentioned word list memory 
test. The maximum possible number of correct responses 
is 10. Savings scores were computed by comparing the 
amount of information recalled on the delayed trial to 
the number recalled on the last (third) learning trial of 
7. Word list rec- . .  
the word list. 
The remaining test assesses 
recognition of the words shown in the word list memory 
task when presented among 10 distractor words, with a 
maximum possible score of 10 for correct recognition of 
the targets and a maximum score of 10 for correct dis- 
crimination of distractors. 
Three of the neuropsychological test measures were 
excluded from further consideration in the analyses due 
to extreme floorkeiling effects in both AD groups (de- 
layed recall, word list recognition) or because of substan- 
tial correlation with other measures (savings scores 
dropped; correlation with word list learning: r = 0.93). 
Statistical procedures. Descriptive statistics (means, 
standard deviations, and percentages as appropriate) 
were computed for the two groups on the demographic 
variables, on disease-related measures, and on each of 
the five cognitive measures; multivariate analysis of 
variance was used to compare the cognitive measures be- 
tween the two groups. Because age, sex, education, dura- 
tion of illness, and degree of functional impairment (as 
measured by the Blessed Dementia Rating Scale and 
CDR scores) are possible correlates of the cognitive mea- 
sures, these covariates were examined as potential effect 
modifiers and confounders of the relationship between 
race and performance on the five remaining neuropsy- 
chological measures (fluency, naming, MMSE, word list 
learning, and praxis). For example, if the effect of race on 
MMSE score were to be different for males and females, 
then sex would “modify” the effect of race on MMSE 
score and would be considered an effect modifier. On the 
other hand, an apparent relationship between race and 
MMSE score might be due to the association of each with 
a third variable, such as education. In this latter exam- 
ple, education would be considered a confounder of the 
relationship between race and MMSE score. 
The examination of effect modifiers was accomplished 
by testing the significance of statistical interactions be- 
tween an indicator variable for race and the six covari- 
ates (ie, age, sex, education, estimated duration of ill- 
ness, Blessed Dementia Rating Scale score, and CDR 
score) in multivariate regression models; each model in- 
cluded the indicator variable for race and all six covari- 
ates in addition to the interaction of interest. These mul- 
tivariate tests revealed that none of the six interactions 
was statistically significant. 
The examination of potential confounders of the effect 
of race on the cognitive measures was accomplished by 
comparing the coefficient of the indicator variable for 
race in a regression model that  contained all six covari- 
ates with the coefficient of the indicator variable in “re- 
duced’’ models in  which one or more covariates were 
omitted. Any covariate that could not be omitted without 
causing a meaningful change in the race coefficient was 
included in the final model as a confounder (without re- 
gard to the statistical significance of the coefficient). Of 
the six covariates, only sex could be removed from the 
model without causing a meaningful change in the race 
coefficient for a t  least one of the five neuropsychological 
measures. Thus, age, years of education, estimated dura- 
tion of illness, Blessed Dementia Rating Scale score, and 
CDR score were all included in the final model, a multi- 
variate analysis of covariance, which was used to evalu- 
ate the relationship of race to the five neuropsychological 
measures. 
Post hoc univariate comparisons of the five neuropsy- 
chological measures and 95% confidence intervals for the 
effect of race, adjusted for the effects of the five covari- 
ates, were based on the multivariable regression models. 
All statistical analyses were carried out using SAS (SAS, 
version 6.04, SAS Institute, Cary, NC, 1991). 
Results. Table 1 shows that the black subjects 
were older than the whites, had fewer years of for- 
mal schooling, and had somewhat more severe de- 
mentia. Although both the black and the white pa- 
tient groups included more women than men (as 
Table 1. Demographic and disease characteristics 
of 830 white patients and 158 black patients with 
Alzheimer’s disease 
White Black 
Characteristic Mean SD Mean SD 
Age 71.8 8.0 74.0 7.8 
Education (yr) 12.6 3.5 10.6 4.2 
Duration of disease (yr) 4.4 2.7 3.5 2.4 
BDRS score 4.5 2.5 5.1 2.7 
CDR score 1.5 0.6 1.6 0.7 
Male (%) 43.5 - 26.6 - 
BDRS Blessed Dementia Rating Scale. 
CDR Clinical Dementia Rating scale. I 
expected in a study of AD), there were proportion- 
ally fewer black men than white men (27% versus 
44%). However, gender did not appear to be a con- 
founder, as it did not affect the race coefficient for 
any of the neuropsychological measures, as stated 
previously. Estimated duration of illness was some- 
what less in the black patients despite the more se- 
vere symptoms reported. 
Table 2 shows the scores on the five neuropsy- 
chological measures for black and for white pa- 
tients. Given the differences in age, education, and 
severity of dementia between the two groups, the 
neuropsychological scores of the black patients 
were lower (as might be expected) than those of the 
white patients (F[5,9821 = 19.43, p < 0.001). 
Age, education, estimated duration of disease, 
and severity of illness were controlled in all subse- 
quent analyses in an effort to explore the effects of 
other racial factors (table 2, adjusted means). Anal- 
ysis of outcomes on the five neuropsychological 
measures (naming, word list learning, praxis, 
MMSE, and fluency), adjusted for the effects of the 
five covariates, indicated a highly significant differ- 
ence for race (F[5,9771 = 12.99, p < 0.001). Al- 
though black patients tended to perform worse 
than whites on all nearly measures, univariate 
comparisons revealed statistically significant dif- 
ferences between the two racial groups for only 
three measures: naming ( t  = 7.21, p < O.OOl), 
MMSE ( t  = 2.59, p < 0.01), and constructional 
praxis (t = 2.72, p < 0.01). 
Discussion. Our findings indicated that black pa- 
tients with AD performed worse than white pa- 
tients on several of the C E W  neuropsychological 
measures. These differences persisted even after 
controlling for confounding characteristics, such as 
differences in age, education, estimated duration of 
disease, and severity of dementia, but performance 
was not equally affected on all the neuropsychologi- 
cal tests. Black patients performed significantly 
worse than whites on the MMSE, on the construc- 
tional praxis test, and particularly on the naming 
of line drawings. These findings are consistent with 
reported observations26 of lower scores on the 
Table 2. Neuropsychological test scores of 830 white patients and 158 black patients with Alzheimer‘s 
disease I Test White Black Adjusted means* Mean (SD) Mean (SD) White Black Difference 95% CI 
Naming 10.78 (3.50) 8.12 (3.44) 10.67 8.69 1.98 (1.44,2.52) 
Word list learning 7.41 (4.55) 6.89 (4.76) 7.33 7.34 -0.01 (-0.71,0.69) 
Praxis 7.07 (2.82) 5.87 (2.92) 6.97 6.37 0.60 (0.17, 1.03) 
MMSE 17.68 (5.60) 15.63 (6.57) 17.52 16.48 1.04 (0.25, 1.83) 
Fluency 7.67 (4.26) 6.68 (3.98) 7.58 7.20 0.38 (-0.29, 1.05) 
* Mean score8 adjusted for the effects of five covariates: age, education, duration of disease, and disease severity as measured by the 
Blessed Dementia Rating Scale and by the Clinical Dementia Rating scale. 
CI Confidence interval. 
MMSE Mini-Mental State Examination. 
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Boston Naming Test in normal elderly black sub- 
jects compared with age-matched white controls. 
Our findings are also consistent with those ob- 
tained in epidemiologic studies and community 
s ~ r v e y s ~ ~ - ~ ~  that showed that the MMSE and simi- 
lar cognitive screening measures resulted in high 
false-positive rates for dementia in blacks. Con- 
versely, other r e p o r t ~ ~ ~ v ~ l  suggest that  education, 
not racial group per se, significantly affects MMSE 
scores in normal elderly persons. This discrepancy 
between clinical and epidemiologic studies may be 
due to other differences in the samples, such as so- 
cioeconomic status, which is known to affect MMSE 
scores.32 
Of note is our finding that the score on the mem- 
ory measure (word list learning) was approxi- 
mately the same in the black and the white sub- 
jects. This finding is in contrast to the results of a 
study7 in a somewhat younger sample of randomly 
selected black, Hispanic, and white community res- 
idents on a 20-item word list memory test. In that 
study, with age, sex, and education controlled, el- 
derly black subjects showed significantly worse 
performance on list learning and delayed recall. 
These findings suggest that AD may be a “race lev- 
eler’’ on learning and memory measures, so that 
any preexisting differences between groups on 
these measures are outweighed by the dementing 
process. The disease may result in a complete or 
nearly complete loss of recent memory function, 
thereby negating any previous advantages con- 
ferred by cultural or experiential background. 
Our earlier studies showed that delayed recall 
and savings scores are highly sensitive to the early 
stages of AD33934 but are relatively unaffected by 
age, education, and gender.35 The findings on these 
two measures were not included in this investiga- 
tion for reasons discussed earlier. Because these 
measures were highly intercorrelated with the 
word list learning procedures,17 we expect that 
there would not be race differences on delayed 
memory and savings scores. If these findings are 
confirmed by others, then tests of learning and 
memory may be particularly important measures 
to include in future cross-cultural studies of aging 
and dementia. Since these cognitive measures are 
not as affected by racial factors, performance on 
the learning and memory measures may permit 
less ambiguous diagnosis of cognitive impairment 
in diverse cultural groups. 
A caveat is necessary in interpreting the find- 
ings reported here. Our study groups consisted en- 
tirely of patients with a diagnosis of AD. Since 
cerebrovascular disease is often present clinically 
and at  autopsy in elderly black patients with de- 
mentia,36-38 some of the differences between the 
racial groups in this study may possibly reflect the 
effects of comorbid cerebrovascular disease. This 
possibility is highly unlikely, however, because all 
the patients with AD in this CERAD study had ex- 
tensive medical evaluation, including neuroimag- 
ing studies, to exclude the possibility of major cere- 
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brovascular disease. We are looking at  the effects of 
vascular risk factors (eg, hypertension) and less se- 
vere cerebrovascular disease in our continuing 
studies. 
Regardless of cause, the finding of a significant 
difference in cognitive function in the two racial 
groups (even after adjusting for education, age, and 
other characteristics) is noteworthy. These observa- 
tions, along with the growing evidence from similar 
 report^,^^^.^^ strongly suggest the need for norma- 
tive information in minority groups. This is an im- 
portant point to keep in mind when evaluating pa- 
tients from minority or other cultural groups. 
There may be differences in educational experi- 
ences across groups that are not completely con- 
trolled for through statistical covariance or by ap- 
plying white educational norms. Specifically, the 
quality of education may not be captured by simply 
adjusting for years of education. Additionally, clini- 
cians should be aware that cultural differences in 
the reporting of disease symptoms may also be op- 
erating across groups, leading to differences in the 
reported symptoms as well as in the estimates of 
disease duration.40 For example, a higher tolerance 
for the cognitive effects of aging in one group could 
lead to later medical attention for the dementia 
and result in the appearance of more severe symp- 
toms over a shorter duration of disease. Studies are 
needed on the possible role of these various socio- 
cultural differences, health characteristics, and 
other demographic factors (such as socioeconomic 
status) on the natural history of AD in black and 
white patients and on the reporting of disease 
 symptom^.^^,^^ 
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